Skip to main content

Indo-Australian Biotechnology Fund (IABF) 2019 Apply Now

www.yourbiotech.in


Department of Biotechnology Ministry of Science & Technology Government of India  Indo-Australian Biotechnology Fund  CALL FOR PROPOSALS (11th Round)  Applications are invited for joint research projects to be implemented by Indian scientists in collaboration with the Australian counterparts. The priority areas of research for Round Eleven of the Indo-Australian Biotechnology Fund are:  1. Plant genomics  2. Neurodegenerative diseases, including palliative care  Call for proposal is open from 14th December, 2018   to 23rd January, 2019.



ABOUT THE PROGRAM  
The Indo-Australian Biotechnology Fund (IABF) is a platform for bilateral collaboration in science jointly managed and funded by the governments of India and Australia. Since its establishment in 2006, the IABF has supported collaborative, leading-edge research between scientists in Australia and India across a range of agreed priority areas. 

It has also helped to build linkages between premier research and educational institutions in both countries. 

The objectives of the IABF are to:

  1. Increase the uptake of leading edge science and technology (S&T) by supporting: collaboration between Indian and Australian researchers in strategically focussed, leading edge, scientific research and technology projects; and strengthening strategic alliances between Indian and Australian researchers. 
  2. Facilitate India and Australia’s access to the global S&T system.  

The Indo-Australian Biotechnology Fund is managed jointly by the Department of Biotechnology (DBT), Government of India and Department of Industry, Innovation and Science (DIIS), Australian Government. 



www.yourbiotech.in




GRANT OPPORTUNITY UNDER ROUND ELEVEN OF THE IABF :
Support is provided under Indo-Australian Fund for S&T Cooperation in Biotechnology (Indo-Australian Biotechnology Fund) for Bilateral collaborative research projects involving Indian & Australian partners. An application should clearly demonstrate that the activities will ‘add value by achieving something worthwhile that would not occur without the grant’.

Under the IABF, the Indian Government will contribute towards the direct costs of bilateral activities in one of the priority areas for collaboration  Higher budget can be provided to projects which engage industry and other end user partners in research activities.  Examples of an ‘end user’ partner include for-profit industry bodies and companies, not-for-profit organizations, non-government organizations and public sector agencies. 

End-users may be located in any country but should be able to provide benefits to both the countries. This must be taken into account when drafting the project plan and budget.   

The grant will be provided for 3 years with a maximum cap of Rs. 2.5 crores. Further information is available on the DBT website: http://www.dbtindia.nic.in 


OTHER GOVERNMENT FUNDING IABF : grants are not intended to duplicate support available from other sources, including other Indian Government funding mechanisms. Where applicants already receive Indian 


DURATION OF ACTIVITIES
Projects may be submitted for financial support for three years.  Indian Government support will not be provided for activities undertaken or expenses incurred prior to the execution of a funding agreement


PRIORITY AREAS :
The priority areas of research for Round Eleven of the Indo-Australian Biotechnology Fund are:   
1. Plant genomics  
2. Neurodegenerative diseases, including palliative care.


TIMELINES FOR ROUND ELEVEN OF THE IABF
The call for applications under Round Eleven of the IABF will be open for Six weeks. The round will open at 10.00 am (IST) on 14th December, 2018, and close at 5.30 pm (IST) on 23rd January, 2019. The table below summarises the steps and indicative timing for the selection process for Round Eleven: 


Important dates :
www.yourbiotech.in



ELIGIBILITY CRITERIA
To be eligible to apply for funding under the Indo-Australian Biotechnology Fund, the Indian applicant must: 

  1. Submit an IABF application in one of the priority areas of research 
  2. Be one of the following ‘eligible organisations’ (or a consortium of eligible organisations):  Indian Education institution;  Indian Cooperative Research Centre / University; Indian Public research company; Indian Private research company; Indian State/Territory-funded research organisation; Indian not for profit research organisation; or  Other Indian incorporated entity; 
  3. Be from an organisation that is registered under DSIR, is incorporated or if a university, is exempt from income tax; and 
  4. Have at least one Australian partner and confirmation from the implementing Australian agency that a corresponding application from that Australian partner has been received (this confirmation will be obtained by the Indian Government).
  5. Joint applications involving more than one Indian partner are acceptable, provided the lead applicant is the main driver of the project and eligible to apply. 
  6. IABF projects should ‘link Indian and Australian research institutions, as well as other end-user partners, collaborating on a single substantial project or conducting a range of research-related activities in a specified field. These Projects may be used as a catalyst to bring together leading institutions in India in a particular research field with Australian partners to help build research capacity and maximise the application, commercialisation and sustainability of research outcomes in support of economic growth and development in India. While not mandatory, involvement by other end-user partners is strongly encouraged and funding will be aimed at Projects that can demonstrate a clear path to end use in support of economic growth and development in India and Australia. 

www.yourbiotech.in




SUBMITTING AN APPLICATION :
Applicants for funding should submit completed application form only in the format provided. Five (5) hard copies and a soft copy in a CD and one soft copy through single  e-mail) with all relevant, clearly labelled attachments to the following address:   

Dr. Suraksha S. Diwan, Scientist ‘E’ Department of Biotechnology  Ministry of Science & Technology  
Block No: 3, 5th Floor, 
Room No. 517 CGO Complex, 
Lodhi Road  New Delhi – 110 003 
INDIA  
E-mail : ssdiwan.dbt@nic.in 



Download Guidelines


Download Application Format



INFORMATION REQUIRED IN THE APPLICATION
The application contains the following pages and fields, which must be completed as described below:  8.2.1 APPLICANTS’ DETAILS Organisation name and type: the eligible organisation (see Eligibility Criteria) being an Indian legal entity, which if successful, will enter into a contractual funding agreement with the Indian Government. Project Coordinator: the researcher who will manage the project. Contact Officer: the officer nominated to receive all correspondence in relation to the application, including the round outcomes. If the applicant is from a University, the Contact Officer must, where possible, be from the University’s Research Office. 


PROJECT DETAILS :

  1. Project Title: limited to 200 characters or 25 words. 
  2. Activity Type: A collaborative research project.  
  3. Priority Area of Research: select the most appropriate priority area of research  Tentative Proposed start date and finish date: please note that projects may only span up to a maximum of 3 years in duration.   Number of Indian and Australian personnel participating in the project. Amount of Indian and Australian funding sought for the project. 
  4. Project Summary: provide a summary of the project, including aims and objectives.  Use plain-English, non-technical terminology (maximum of 200 words). 
  5. Expected Outcomes: detail the anticipated outcomes of the project. Specify the key outcomes, including any joint publications, from the original IABF funded project - whether completed or nearing completion and explain how the proposed project will bring the research closer to end-use stage. Use plain-English, non-technical terminology (maximum of 200 words).  
  6. Project Snapshot: provide a brief, non technical, overview of the project objectives which, if successful, may be used to publicly promote the project (maximum of 50 words) 



PROJECT PARTNERS
Indian partner(s): provide contact details of each Indian partner.  
Australian partner(s): provide contact details of each Australian partner.  


PROJECT PLAN AND BUDGET
Project phase details : a maximum of 6 activities can be inserted and each must include: 

  1. the activity name;
  2. funding sought for the activity from the IABF;
  3. a description of the activities to be undertaken during the activity, including a detailed costing/breakdown of eligible expenses to be supported using IABF funding. 
  4. a list of the key personnel that will be involved in the activity; 
  5. the expected outcomes from the phase activities; and 
  6. measurable performance indicators against the phase activities. Contributions: applicants do not need to demonstrate that the Indian contribution (cash and/or in-kind) to the project matches or is more than the funding sought from the IABF.  However, the level of support (cash and/or in-kind) for the project from Indian and Australian organisations  (including  the  applicant’s  own  organisation)  will  be  considered  in  the assessment  of  the  proposal  (see  Assessment  Criteria  and  Cash  and  in sources).




INTELLECTUAL PROPERTY RIGHTS Applicants  must  provide  details  of  the  Intellectual  Property  (IP)  issues  in  their  applications. This  includes  both  the use  of  IP  in  the  project  and  the  proposed  ownership  of  rights  of  IP generated  by  the  project  as  well  as  strategies  for  protecting  India’s  interests. Where  IP  is likely  to  be  generated  by  the  project  successful  applicants  will  be  required  to  conclude protoc ols  or  contracts  with  their  Indian  partners  on  the  management  of  IP  issues.  These agreements  should  be  in  accordance  with  laws  and  regulations  prevailing  in  India  and Australia  and provide  for: 

  1. adequate  and effective  protection and equitable distribution of any  benefits  from  IP  rights created in or resulting  directly  from cooperative  activities (foreground  IP  rights), ownership of  foreground  IP  rights to be  allocated  on the basis  of respective  contribution and equitable interests, terms and conditions for the commercialisation and other  forms of dissemination of  the foreground  IP  rights, and Adequate and  effective  protection  of  IP  rights  provided  by  the  organisations,  enterprises and  institutions  prior  to  or  in  the  course  of  such  cooperative  activities,  fo r  example  the licensing  or utilisation of  such  IP  rights on  equitable terms (background  IP  rights). Please  note  that a written  agreement duly signed  by both Indian  and  Australian partners is  mandatory to be  provided  alongwith /in Eleven 201 8 1 9 of  the Indo the  application. Australian Biotech  Fund 19 Guidelines  for Round.

Popular posts from this blog

How the Mammary gland stem cells activates during time of puberty

High resolution imaging of ducts in the mammary gland was critical for the discovery of how their growth is triggered in puberty. Credit: Walter and Eliza Hall Institute, Australia A group of researcher from Walter and Eliza Hall Institute, Australia has got milestone in how the growth of milk producing mammary glands are triggered during the period of puberty. They have recently published it's paper today in journal of "Developmental cell" According to published paper they discovered that sleeping stem cell in the mammary gland are awoken by FoxP1 Transcription factor. Highlight of Fox1 Fox p1 is transcription factor which is essential for mammary glands growth and development and it control the activation of quiescent MaSCs  marked by Tspan8. Fox1 directly repressed the transcription of Tspan8 in basal but , not in luminal cells. Tspan8 deletion rescue the Foxp1 deficient mammary phenotype. The researchers enlighten our knowledge of how the mammar...

Top 11 best biotech and Pharma companies in Aurangabad

Top 11 best biotechnology and pharmaceutical companies in Aurangabad Biotechnology and pharma is most illuminating companies throughout the world generally most of biotech and pharma companies are situated in cities like Mumbai, pune, Delhi, Hyderabad, Biotech companies in bangalore , Chennai and others cities now Aurangabad is emerging as biotech and pharma hub for Maharashtra state people's, students. If you are looking and searching for best biotechnology and pharmaceutical companies in Aurangabad for different reasons.... top-10-best-biotech-companies-in-india. Here are top 11 best Biotechnology and pharmaceutical companies in Aurangabad 1. Wockhardt Biotech Park / wockhardt research center Wockhardt is pharma and biotech company providing affordable, high quality medicines, for healthier world,It is multinational company with multiethenic workforces. It has 3 research center and 12 manufacturing plant, produce pharma and biopharma formulation and active pharma in...

ICGEB- short term fellowship | yourbiotech

ICGEB - short term fellowship  SMART scheme - scientific mobility for advanced research for training program are conducted for Msc. candidates, young researchers with backgraound in life science are eligible to apply for this ICGGB short- term fellowship. closing date for application 31 march ,30 sep , 31 december. Aim -:      The fellowship promotes the mobility of researcher involving the ICGB member states as a way of enhancing skill development, acquistition of specific hands on training in new technologiest and increasing bilateral cooperation in science and technology and it should show clear evidence of strong collaboration between the two laboratories.         subject area -:               Application are welcome in any area of the life science. Qualification -:  - There is absolutely no age limitation preference is awarded to young scienticst at the state of their...